SCHEMBL3304872

SCHEMBL3304872

COc1cc(-c2nnc(OC(N)=O)n2-c2cc(C(F)(F)F)ccc2C(F)(F)F)c(O)cc1O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.35
SCN9A Q15858 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 1/20 0.35
PDE2A O00408 2/20 0.34
PDE10A Q9Y233 1/20 0.34
NR1I2 O75469 1/20 0.33
CXCL12 P48061 1/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HSP90AA1 P07900 2/20 0.33
TSHR P16473 2/20 0.33
CYP1A2 P05177 1/20 0.33
NFKB1 P19838 1/20 0.33
CYP2C19 P33261 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
KCNMA1 Q12791 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL931411 0.84 MEN1 (0.36) PDE2APDE10ACXCL12MAPTMEN1
SCHEMBL14184120 0.84 MEN1 (0.46) CYP3A4MAPTMEN1KMT2ATSHR
SCHEMBL14184123 0.73 TUBB4A (0.39) HSP90AA1TSHRALDH1A1
SCHEMBL12180287 0.72 KMT2A (0.38) MAPTMEN1KMT2AHSP90AA1NFKB1
SCHEMBL8931051 0.67 HSP90AA1 (0.40) MAPTHSP90AA1TSHRABCG2ABCB1
SCHEMBL930396 0.66 APLNR (0.45) MAPTMEN1KMT2ATSHRCYP1A2
SCHEMBL12908734 0.65 PDE4D (0.37) MAPTMEN1KMT2AHSP90AA1TSHR
SCHEMBL15468253 0.63 HSP90AA1 (0.40) CYP2C9CYP3A4CYP2D6NR1I2MAPT
SCHEMBL1344632 0.63 ALDH1A1 (0.36) NR1I2CXCL12TSHRABCG2ABCB1
SCHEMBL930673 0.62 SLC37A4 (0.37) MAPTMEN1KMT2AHSP90AA1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188075-B2 Triazole compounds that modulate HSP90 activity SYNTA PHARMACEUTICALS CORP. (US) 2012-05-29 US disclosed
US-20100093717-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093717-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY HSP90AB1, HSP90AA1, HSP90AB2P CYP2C9 2343/4885SCN9A 4294/4885CYP3A4 1844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.